The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(6-(5-chloro-2-fluorophenyl)-1H-pyrrolo[2,3-b]pyridin-4-ylamino)-N-cyclopropylnicotinamide ID: ALA4483492
PubChem CID: 155540539
Max Phase: Preclinical
Molecular Formula: C22H17ClFN5O
Molecular Weight: 421.86
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NC1CC1)c1cnccc1Nc1cc(-c2cc(Cl)ccc2F)nc2[nH]ccc12
Standard InChI: InChI=1S/C22H17ClFN5O/c23-12-1-4-17(24)15(9-12)20-10-19(14-5-8-26-21(14)29-20)28-18-6-7-25-11-16(18)22(30)27-13-2-3-13/h1,4-11,13H,2-3H2,(H,27,30)(H2,25,26,28,29)
Standard InChI Key: LJLGIVAKWSPARG-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
3.0651 -19.5672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0640 -20.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7720 -20.7957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7702 -19.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4788 -19.5636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4791 -20.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2621 -20.6409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7458 -19.9748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2617 -19.3090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7678 -18.3411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0589 -17.9346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0598 -17.1182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3517 -16.7118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6442 -17.1225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6493 -17.9439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3579 -18.3466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3578 -20.7950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6502 -20.3841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9426 -20.7915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9415 -21.6096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6539 -22.0186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3585 -21.6088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0670 -22.0161 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.7672 -16.7091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4752 -17.1171 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7666 -15.8919 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1826 -16.7080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9966 -16.7063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5875 -15.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2354 -20.3820 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
2 17 1 0
22 23 1 0
12 24 1 0
24 25 1 0
24 26 2 0
25 27 1 0
28 27 1 0
29 28 1 0
27 29 1 0
19 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 421.86Molecular Weight (Monoisotopic): 421.1106AlogP: 5.05#Rotatable Bonds: 5Polar Surface Area: 82.70Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.97CX Basic pKa: 6.64CX LogP: 5.06CX LogD: 5.00Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.42Np Likeness Score: -1.36
References 1. Wang H, Lawson JD, Scorah N, Kamran R, Hixon MS, Atienza J, Dougan DR, Sabat M.. (2016) Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors., 26 (17): [PMID:27460209 ] [10.1016/j.bmcl.2016.07.030 ]